Based on these observations, we further investigated in vitro and in vivo the effect of MET given alone or in combination in the TMZ-sensitive U251 GBM cells and explored its potential efficacy on the TMZ-resistant T98G GBM cells. The gene discussed is MET; the disease is glioblastoma.